Chronic Myeloproliferative Disorders Completed Phase Trials for Filgrastim (DB00099)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00290641Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic CancerTreatment
NCT00296023Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic CancerTreatment